Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Elliott Management ousted much of the board at Southwest Airlines, with Gary Kelly announcing his retirement amid broader board turnover.
Shares in major video game publisher Ubisoft took an over 7% hit on Monday after a minor investor’s letter.
On Monday, the Murdoch family was once again asked the $15 billion question: Who will take over the company after Rupert is no longer around?
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Boeing reached a tentative deal with the union representing its production workers in Washington state, likely dodging a strike.
American Transit Insurance Company (ATIC) insures over 60% of 117,000 taxis and for-hire vehicles. And it’s insolvent.
Some fans found that while they were waiting to buy Oasis tickets, the prices had quietly crept up from £135 ($177) to £350 ($460).
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Copyright issues make it difficult to substitute creative labor in game development, one expert said.
The Abu Dhabi National Oil Company (ADNOC) signed a deal with Exxon to buy a 35% share of a new hydrogen plant just outside Houston, Texas.
Data from two promising vaccine trials heralded potential breakthroughs in the treatment of pneumococcal infection and Lyme disease.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.